Señales en vivo de 300725.SZ | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 03:04):

PharmaBlock Sciences (Nanjing), Inc. provides chemistry products and services throughout the pharmaceutical research and development, and commercial production...

Stats
Volumen de hoy	7.13M
Volumen promedio	7.36M
Capitalización de mercado	6.58B
EPS	CNY0.199 ( 2023-10-30 )
Próxima fecha de ganancias	( CNY0 ) 2024-05-17
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	35.52
ATR14	CNY0.0670 (0.20%)

Volumen Correlación

Largo: 0.33 (neutral)

Corto: -0.35 (neutral)

Signal:(55.777) Neutral

PharmaBlock Sciences Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

PharmaBlock Sciences Correlación - Moneda/Commodity

0.12
( neutral )

0.13
( neutral )

0.00
( neutral )

-0.05
( neutral )

0.11
( neutral )

-0.25
( neutral )

PharmaBlock Sciences Finanzas

Annual	2023
Ingresos:	CNY1.71B
Beneficio Bruto:	CNY676.83M (39.66 %)
EPS:	CNY0.990

FY	2023
Ingresos:	CNY1.71B
Beneficio Bruto:	CNY676.83M (39.66 %)
EPS:	CNY0.990

FY	2022
Ingresos:	CNY1.59B
Beneficio Bruto:	CNY725.20M (45.48 %)
EPS:	CNY1.570

FY	2021
Ingresos:	CNY1.20B
Beneficio Bruto:	CNY578.29M (48.13 %)
EPS:	CNY2.46

Financial Reports:

No articles found.

PharmaBlock Sciences

PharmaBlock Sciences (Nanjing), Inc. provides chemistry products and services throughout the pharmaceutical research and development, and commercial production. It primarily businesses include building blocks collection, supplying from discovery, development to commercial; building blocks driven libraries for drug discovery; development and manufacturing of RSMs, intermediates, APIs, and drug products for drug development and commercial. The company was founded in 2006 and is based in Nanjing, the People's Republic of China.